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ABSTRACT
The LIVESTRONG Centers of Excellence were funded to
increase the effectiveness of survivorship care in
oncology practice. This study describes the ongoing
process of adopting and implementing survivorship care
using the framework of the diffusion of innovation theory
of change. Primary data collection included telephone
interviews with 39 members from the eight centers and
site visits. Organizational characteristics, overall
progress, and challenges for implementation were
collected from proposals and annual reports. Creating an
awareness of cancer survivorship care was a major
accomplishment (relative advantage). Adoption
depended on the fit within the cancer center
(compatibility), and changed over time based on trial and
error (trialability). Implementing survivorship care within
the existing culture of oncology and breaking down
resistance to change was a lengthy process (complexity).
Survivorship care became sustainable as it became
reimbursed, and more new patients were seen
(observability). Innovators and early adopters were crucial
to success. Diffusion of innovation theory can provide a
strategy to evaluate adoption and implementation of
cancer survivorship programs into clinical practice.
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BACKGROUND
An aging population and the earlier detection of
cancer through screening have increased the number
of cancer patients, and more effective therapies have
enabled people to live longer with cancer [1]. Added
to this is the prediction that there will be insufficient
numbers of oncologists available to meet the needs of
cancer patients as well as survivors in the future [2].
Cancer survivors are not only at increased risk for
developing a second cancer but also, as they age, for
chronic illnesses that can affect survival [3]. Thus,
there is an increasing need for posttreatment survi-
vorship care to promote healthy lifestyle behaviors,
such as smoking cessation, physical activity, nutrition,
and a healthy weight; surveillance for new and
recurring cancer and late effects of treatment; inter-
ventions for the consequences of cancer and its
treatment; and care coordination [3].
Between 2004 and 2008, a number of National
Cancer Institute-designated comprehensive cancer
centers were invited to respond to an invitation
from the Lance Armstrong Foundation (LAF) to
apply for grant funding that would provide the
LIVESTRONG Survivorship Center of Excellence
(COE) Network designation and infrastructure
support for program development. Eight centers
successfully competed for funding to join the
network, and each program identified three com-
munity affiliates as partners. The goals of the
LIVESTRONG Network are to (1) increase the
quality of life for cancer survivors, (2) transform
how survivors are treated and served, (3) contribute
to the collective body of knowledge on survivor-
ship, (4) increase the accessibility and quality of
services for survivors, and (5) explore reimburse-
ment issues and develop financial strategies to cover
the cost of survivor care [2]. Network goals are
accomplished by the COEs working collaboratively
with one another and their community affiliates to
identify best practices and develop models of care
that will provide cancer survivors with comprehen-
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Implications
Practice:Recognizing barriers and facilitators for
change when introducing a new practice (cancer
survivorship) into oncology services is essential
for program success.
Policy:
Adequate and continuing resources along with
organizational commitment and support are essen-
tial for adoption and implementation of cancer
survivorship care into clinical care.
Research:
Research to identify what does and does not work in
the process of adopting and implementing survivor-
ship programs in a clinical setting should occur from
the beginning to make sure programs continue.
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sive medical follow-up for recurrence and late
effects, screening for second cancers, developing
ongoing wellness initiatives as well as building
support services for survivors, education for health
providers and survivors, and building community
initiatives and partnerships [2]. Collaborative re-
search is also an overarching goal of the network,
and there have been and continue to be a number of
research projects conducted across the network.
In 2008, the LAF funded a study to examine the
clinical survivorship care and organizational charac-
teristics of the eight COEs and provide key recom-
mendations for future efforts. Using both
quantitative and qualitative data, findings from the
study offered support for several domains of the
chronic care model (CCM) which emphasizes the
importance of six elements essential to improve
chronic illness care: health system organization,
delivery design, clinical information systems, self-
management care, decisional support, and commu-
nity linkages [4]. A major issue that emerged from
the qualitative data was the experience of the COEs
in adopting and implementing the survivorship care
programs into the oncology practices of their
institutions. The current manuscript presents find-
ings related to this process using the framework of
diffusion of innovation theory.
Diffusion of innovations theory
Diffusion of innovations is a theory of social and
cultural change developed over 50 years ago by
Everett Rogers [5]. As defined by Rogers, diffusion
of innovations is a process, not a discrete event,
through which an innovation, defined as a new idea,
practice, or object, unfolds over time through the
communications networks of members of a system
[5]. According to Rogers, there are five elements
that make an innovation more likely to be adopted
over time: (1) there is a relative advantage over what is
currently being done; (2) it is compatible or fits with
organizational or professional culture and values,
norms, perceived needs, and ways of working with
little disruption; (3) it is not difficult to understand
and there are few barriers to overcome (complexity);
(4) it can be tried on a limited basis (trialability); and
(5) the benefits are visible to others (observability). If
potential adopters can adapt, refine, or otherwise
modify the innovation to the local context, it will
also be adopted more easily [5]. New concepts
usually come from outside the current system, but
for change to occur, processes need to come locally
from inside the system [6]. Individuals or organiza-
tions adopt innovations at varying rates. Innovators
can imagine the possibilities and are eager to try it
out; early adopters learn about the advantages from
innovators and make a connection between the new
practice and the needs; others (early majority adopters,
late majority adopters) follow as they see the advan-
tages, and laggards are the last to adopt, if at all [5].
A great deal of research in a variety of academic
disciplines has been conducted on the diffusion of
innovations since the development of the theory. The
majority of diffusion studies rely on quantitative data,
usually via surveys, and study the rate of adoption of a
single innovation at a single point in time after
widespread diffusion has already taken place [7]. The
innovation is most often a simple, product-based
innovation, for which the unit of adoption is the
individual and diffusion occurs by means of simple
imitation [5]. When the unit of adoption is a complex
organization, the aforementioned “standard” charac-
teristics of an innovation are necessary but not
sufficient to explain or guarantee the adoption and
implementation of complex innovations in organiza-
tions [8]. The rate of adoption depends on the
interaction among a particular innovation, the
intended adopter and the situational context [8].
The adoption of a new clinical practice is not a linear
process; and scientific evidence, although useful, is not
sufficient in itself for diffusion of a new practice or
behavior [9, 10]. In practice, medical behavior is
shaped as much by experience and peer comparison
as by scientific evidence from randomized clinical
trials or other high-quality studies [9]. Decisions about
implementing best evidence practices are driven by
the interplay between the interests of the patient, the
clinician, and the healthcare system [11]. We need to
understand more about the adoption and implemen-
tation process if we want to accelerate incorporation of
evidence-based programs into practice to improve
health care quality. Although much attention is
currently focused on dissemination and implementa-
tion research, relatively few theories and models have
been applied to studying this in the context of




Study data collected from the eight participating
COEs is listed in Table 1. Three primary sources of
qualitative data were collected: program data,
telephone interviews, and site visits. Program data
were collected from the eight proposals and 22
annual reports available for analysis at the time of
the study. The reports covered the first and second
years of progress in all COEs and for years 3 and 4
in the five earliest-funded centers. Program data
analyzed for this manuscript included organizational
issues concerning cancer survivorship, models of
care, change over time, prior survivorship initia-
tives, and processes and lessons learned during
COE development. Telephone interviews were com-
pleted with 39 COE members during May and June
2009 (Table 2). With permission, interviews were
audio-taped and transcribed verbatim. An open-
ended interview script utilized the framework of the
CCM [4, 14] and added questions about the
strengths and weaknesses of the COE, challenges
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(lessons learned) for program development, impor-
tant accomplishments of the COE, changes over
time, and the value of survivorship care to oncology
practice. Site visits were conducted in May 2009 with
three of the earliest-funded COEs. Each site visit
lasted 1 day and was led by a two-person staff and
research assistant team. Individual and group meet-
ings were held with COE staff and affiliates, and
observation of facilities was conducted. Field notes
were taken during the visit. Site visits provided
observational data related to operations and facili-
ties, as well as situational background that provided
a more in-depth understanding of issues, institution-
al context, and challenges faced in program devel-
opment. Study protocols and materials were
approved by the Institutional Review Board of the
University of North Carolina at Chapel Hill.
Analysis
Program data (annual reports), transcribed tele-
phone interviews, and site visit field notes were
imported into a qualitative data management soft-
ware program (ATLAS.ti 5.0). Data were reviewed
several times, and a codebook, developed. Content
was coded using the initial framework of the CCM
and additional questions about the COE providing a
preliminary list of codes (deductive), which were
supplemented with emergent codes (inductive) as
analysis proceeded [15]. Data were coded and
analyzed by two independent investigators (IT,
SG). The unit of analysis was the site (COE). The
investigators independently coded a sample of five
interview transcripts, reaching agreement on code
definitions and decision rules and checking inter-
coder reliability until the kappa statistic reached
0.70–0.80. Analysis revealed themes (patterns) de-
termined by the strength, depth and frequency of
concepts, and consistency between the sites (COE),
derived from the coding process.
RESULTS
Themes related to the diffusion process are pre-
sented below with supporting quotes from the
interviews and site visits. These include the follow-
ing: creating awareness (relative advantage); making
the cultural shift and start where they are (compat-
ibility), trial and error (trialability); change is very
hard and very slow (complexity); and the bottom




Creating an awareness of the scope and need for
cancer survivorship care, as opposed to traditional
Table 1 | Data collected from each of the eight cancer centers involved in the study









Memorial Sloane-Kettering Cancer Center 2005 3 5
Fred Hutchinson Cancer Research Center /
Seattle Cancer Care Alliance
2006 3 5
Jonsson Comprehensive Cancer Center,
University of California Los Angeles
2006 3 5
University of Colorado Cancer Center 2006 3 3
Ohio State University Comprehensive
Cancer Center
2007 2 5




Center, University of North Carolina
at Chapel Hill
2008 2 6
a Indicates number of years a COE at the time of the study (2009)
Table 2 | Characteristics of interviewees from the eight COEs
Position n %
Center director or co-director 12 31
Clinical personnel 10 25
Administrators/coordinators 12 31
Other affiliated personnel 5 13
Time with COE
Less than 2 years 11 28
2 years or more 19 49
Since beginning of COE 9 23
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posttreatment care, was considered by many as the
major accomplishment of the COEs. As one re-
spondent said “we're putting survivorship on the
map.” Raising awareness was accomplished through
various educational venues, such as integrating with
the standing lecture series at the cancer center,
adding survivorship-focused talks to preexisting
annual disease-specific patient conferences, online
and in-house continuing medical and nursing edu-
cation courses, presentations for oncology and
primary care practices, grand rounds presentations,
survivorship conferences for health care professio-
nals, and educational events for providers and
survivors in the community.
“The most important accomplishment for the
Center of Excellence, to look at it from the
clinical side, is that it has brought into awareness
in a new way for the treating physicians and for
the cancer center, some of the concerns of
patients after treatment. That's a culture change
that has definitely begun.” (clinical coordinator)
Compatibility/fit
Making the cultural shift
Creating the awareness that survivorship is something
separate and different from traditional oncology care
was a challenge. Oncologists typically focus on treat-
ing and curing active disease and tend to provide
follow-up care and surveillance even when patients are
years posttreatment. As one clinician commented on
shifting this traditional paradigm, “it's moving a freight
train in a slightly different direction.”
“We probably have similar experience to other
people in that it's a change in culture. Everything
is so focused on treatment and the immediacy of
those problems that these patients are the wellest
of the well, so to speak, that come here. They are
not dying and they're not in active treatment so
there hasn't been a lot of emphasis on the
resources they need.” (COE director)
“[Survivorship care] comes from a very long
history of a medical model. We are a very high-
profile, research-evidence-based center, and a lot
of research is geared toward eradicating cancer
and that's what the philosophy is.” (clinical
coordinator)
Resistance to making changes in survivorship care
took several forms: it was already being done;
oncologists did not want to “give up” their patients;
there was little evidence for the effect of survivorship
initiatives on outcomes; there was little time to change
the system of services; and there was limited or no
reimbursement for the services. Survivors also were
attached to providers and felt comfortable there.
While most COEs reported a high level of
commitment from the senior leadership of their
institution, this did not necessarily translate into
buy-in among the practitioners and administrators
throughout the system.
“The leadership of the cancer center is behind
survivorship at the very top. I think that there are
some challenges in the mid-section, if you will,
from both some of the medical leaders being as
enthusiastic as the head of the cancer center and
thereby helping to facilitate things happening.”
(clinical coordinator)
Start where they are
All COEs completed needs assessments to explore
(1) what was currently being done for survivorship
care and education in practices in their institution,
(2) what providers and patients needed and wanted
regarding survivorship care, and (3) how to adapt
survivorship care to make it fit with their site's needs
and constraints. The needs assessments were admin-
istered using a variety of methods (questionnaires,
online surveys, key informant interviews, focus
groups).
COEs started the process of adopting survivorship
care with those oncology practices and individual
oncologist that saw the benefit for their patients.
Some of the COEs started with separate survivor-
Table 3 | Diffusion characteristics, study themes and strategies to promote adoption, and implementation of survivorship care
Diffusion characteristic Themes Strategies for change
Relative advantage–perceived as
better than before
Creating awareness Widespread education
Compatibility/fit – consistent with





Find the best fit for survivorship care with the




Trial and error Flexibility and change in the models of care
that work for the practice and institution
Observability/visibility–tangible
results
The bottom line Funding, institutional support, and
reimbursement
Complexity/ease of use in
understanding or using innovation
Change is very hard
and change is very
slow
Education and training for professional staff to
improve performance
Innovators and early adopters Champions Identify leaders, invest time, and commitment
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ship clinics, relying on individual practice areas to
refer their long-term patients. However, the ultimate
goal for some COEs was to integrate survivorship
care into the various oncology practices. In either
case, the COEs relied on the decision of the
individual oncology practices to see how this was a
fit for them, both in terms of referrals to a separate
clinic or for integration into the practice.
“Selling a package of resources really took some
time, a lot of patience and spending lots and lots
of time with people, particularly the treating
physicians and the nurses, about what would
work in their area and what they thought was
good for them. There are always champions and
there are always naysayers so I started with the




Models of survivorship care and implementation
depended on fit within the cancer center and
changed over time based on trial and error. Virtually
all COEs started with a different model of care from
their current model(s) for survivorship care. Many
used more than one model, depending on the
disease group and setting. All COEs tried out a
number of different models of care before deciding
on which model(s) worked for their institution.
Some models of care worked in one clinic but not
in another. A few COEs were integrating survivor-
ship care into oncology practices, but in some cases,
logistics of time and space constituted a barrier.
Being a part of the LIVESTRONG network of
COEs was helpful to learn about the experiences
others had in the process of adoption.
“It's been an evolution. Every clinic that we start
up, we've learned new things and we've taken
what we've learned from the other clinics, both
successes and failures. We've been able to
expand on the program and have used the
lessons from the previous clinics to improve
upon existing clinics and future clinics.” (Project
administrator)
Complexity
Change is very hard and change is very slow
Changing any system is difficult, especially a health
care system. The complexity in adding survivorship
care to the existing practice of oncology, particularly in
these largemedical institutions, was a major challenge.
Changing culture and building consensus for change is
a lengthy process. This process is multifaceted and a
“moving target,” always evolving and requiring con-
siderable time, effort, and commitment. Programs,
particularly the establishment of survivorship clinical
programs, took longer than expected in most COEs.
“There is an honest realization from my part that
integrating any new service into oncology is a
long-term proposition, just as palliative care took
years to reach a state of being recognized, which
it is now. ” (COE director)
Several factors made this a complex endeavor,
including resistance to change from oncology prac-
tices, piloting numerous models of care, inadequate
staff, and the general logistics of setting up a new
program. Each COE had its own barriers that
slowed down the process.
“There is constant resistance. Every single initia-
tive that I've mentioned has met with resistance
and then eventually it becomes part of the
institution. I think you have to be persistent,
because change doesn't happen overnight.” (COE
director)
To help reduce the perceived difficulty or com-
plexity of the innovation, education and training to
raise awareness and to provide an overview of late
effects of treatment and general guidelines for
providing optimal survivorship care was provided
to nurses, nurse practitioners (NPs), and physicians,




Funds from LIVESTRONG were instrumental in
initiating or enhancing survivorship care. Having the
initial grant funding was considered an important
recognition for these research-oriented institutions,
most of which probably would not have provided the
resources needed for a survivorship care program.
This funding enabled COEs that had already estab-
lished survivorship programs to expand their efforts.
“The funds have been extremely important.
Early on they were critical to be able to get
things up and running and show some momen-
tum and to demonstrate to the powers that be
that this was something that could and should be
done.” (COE director)
“The fact that this new area had national funds
behind it and that there was a grant opportunity,
got a lot of the academic physicians' attention
because that's how they make their careers is
with grants.” (COE director)
A major issue for the COEs was that, for the most
part, survivorship care does not provide significant
reimbursement. Therefore, it was important for the
cancer centers to develop sustainability plans for these
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survivorship programs. COEs accomplished this in
various ways. For example, they demonstrated the
benefit for practices of decreasing the number of long-
term follow-up patients, thus allowing oncologists to
see more new patients, and/or they established
mechanisms of reimbursement for theNPs who staffed
the clinics. The NPs at some COEs were supported by
institutional funds and at others through philanthropy.
“The other big piece of it is in winning over
hospital administrators because the bottom line
is they are interested in budget and what brings
money in or certainly what's a service that adds
value in some way. ” (COE director)
Innovators and early adopters
Champions
Program leaders, steering committees, leadership
teams, and individual oncology groups were crucial
to the success of the COEs. These champions were
the early adopters of this process, helping to break
down resistance for oncology to make that “cultural
shift” to survivorship care as standard practice. The
input of these groups early on was invaluable to
affect these changes and reach a consensus on how
to deliver this kind of care within a particular cancer
center. Getting these opinion leaders involved
helped obtain institutional commitment, which often
included the resources to help sustain the program.
These champions of survivorship care understood
that the existing model for long-term follow-up care
was not sufficient; those visits were very short and
mainly involved evaluation for recurrence. In addi-
tion, oncology practitioners were frequently over-
whelmed, and there was an institutional push to see
new patients rather than the same long-term patients
year after year.
“Because of the oncology work force issues
nationally and locally, people are starting to
realize that they can't hold on to all these patients
and give them adequate follow-up care. There
are just too many patients.” (COE director)
DISCUSSION
Study findings show the experience of the LIVE-
STRONG Centers of Excellence in the process of
diffusing a new practice, survivorship care, into the
existing organizational structure of oncology practice.
Groups involved in setting clinical policy are part of
highly complex networks of social relationships that
affect their practice, and the complexity and variability
of local contexts ensure that there is no one way to
introduce innovations [9]. While each COE is unique
and the best model for survivorship care in each is
dependent on the context and history of the parent
institution, there are similar processes in developing
new programs for cancer survivors in an existing
system. In this study, the characteristics of the diffusion
model (relative advantage, compatibility, complexity,
trialability, and observability) in influencing adoption
and implementation of cancer survivorship programs
were evident. Table 3 summarizes these study findings
and the strategies used by the COEs.
Different organizations provide widely differing
contexts for innovations, and some features of
organizations, both structural and cultural, influence
the likelihood that an innovation will be successfully
adopted into practice [6, 9]. If the innovation starts
out with a budget as well as adequate and continuing
resources, there is a flexible organizational structure,
and top management supports and advocates for the
process with continued commitment, then an inno-
vation is more likely to be adopted [8, 11]. The
COEs had a budget from LIVESTRONG to start
the process and raise awareness; however, this
funding was time-limited. COEs that had stronger
institutional support and developed reimbursement
strategies for survivorship services were further
along in this process. A key determinant of success-
ful innovation is whether the new routine associated
with the innovation aligns rather than conflicts with
organizational and interorganizational routines. If
people are uncomfortable with the status quo and
desire change, a potential innovation is more likely
to be successfully adopted [16]. Alignment with
routines and an understanding of the “culture of
oncology,” as well as flexibility to try an approach
and then change to another approach as needed,
were important attributes in the diffusion process for
the COEs. Oncologists often had to be persuaded of
the relative advantage of a survivorship program:
they tended to want to follow their own patients
indefinitely, even though patients' needs and oncol-
ogists' workloads were issues that needed to be
addressed. To an important extent, timing favored
COE development, in that workforce limitations
were being recognized and published in the same
period as the onset of the survivorship programs.
Center administrations were thus primed to value a
change in the status quo.
The active support and involvement of opinion
leaders was cited repeatedly in the interviews, and
diffusion theory supports the importance of these
program champions to enact change and demon-
strate new ideas to later adopters. The influence of
opinion leaders and champions is a powerful factor
for making organizational changes in a variety of
settings [8]. While impersonal channels of commu-
nication, such as brochures and publicity about a
new program can create awareness of an innovation,
interpersonal influence through social networks is a
dominant mechanism for diffusion [8, 17], particu-
larly as programs develop [18]. If respected and
influential clinicians argue for and demonstrate the
application of a new procedure or treatment ap-
proach, it is likely to have a positive impact upon
adoption rates [19].
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In the case of adopting survivorship care into
standard practice, influence needed to occur at
multiple levels, including top-down support from
administrators and day-to-day buy-in and support
from clinicians, nurses, and other key personnel, as
well as patient feedback. In addition to promoting
the relative advantage and benefits of survivorship
care, these individuals were key for issues such as
finding flexible strategies to promote compatibility,
and providing visibility in their care and referral
patterns. Opinion leaders in administration were
also instrumental in providing other features to
assure survivorship clinic success. This included
such basic resources as space for the clinic, sched-
uling, intake procedures, and other basic resources
required for successful patient care.
For innovations to spread, it takes time, energy,
and money [6]. Facilitators for change for the COEs
included the large number of patients and the need
to make room for new patients, the funding that
started or enhanced efforts, and the early adopters
who helped promote the idea, as well as the time
and energy of those innovators who wrote the grant
to begin the process. Much of the success of the
COEs can be attributed to the vision, persistence,
and hard work of these leaders who devoted time
and energy to pursuing survivorship as a priority in
their institution. Additionally, LIVESTRONG fund-
ing provided the recognition and “branding” to
create an interest and priority in survivorship and
gave a boost to existing survivorship programs.
Barriers to change included resistance from oncol-
ogy practices, lack of financial support from the parent
institution, the logistics of setting up a new program in
a large institution, and the slow pace of change.
Changing the culture of oncology was considered a
major challenge, particularly changing the awareness
of survivorship care needs and overcoming the
reluctance of oncologists to give up a positive aspect
of their practice, i.e., the opportunity to see thriving
survivors. Commitment from the senior leadership of
the cancer center for the survivorship programs did
not necessarily translate into buy-in among the practi-
tioners and administrators throughout the system, nor
did it translate automatically into resources to support
the change. Organizational commitment from the
cancer center at the highest level was necessary for
success but was insufficient to ensure that survivorship
priorities were actualized.
There are several limitations to this study. The
process of diffusion illustrated here does not necessar-
ily apply to all oncology practices. These COEs were
in major research and teaching hospitals, all National
Cancer Institute-designated comprehensive cancer
centers. Research is a major initiative in these high-
profile and high-volume medical centers, and this
often takes priority and resources. Several of the
cancer centers already had begun initiatives to redirect
care of long-term survivors, both adults and children,
and large numbers of oncology patients were long-
term survivors in the large-volume practices of these
medical centers. This may not be true of smaller
hospitals or of private practices.
CONCLUSION
Despite any limitations the diffusion of innovations
framework provides insight into the complex process
of incorporating a new survivorship paradigm into
clinical care. As more cancer survivorship programs
become standard care, this studymay offer insight into
the factors important to consider when affecting
change within the institutional setting.
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